Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates
Crossref DOI link: https://doi.org/10.1007/s40268-016-0164-6
Published Online: 2017-01-11
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sanfilippo, Christine M.
Allaire, Catherine M.
DeCory, Heleen H.
Funding for this research was provided by:
Bausch and Lomb
License valid from 2017-01-11